- Patient Resources
- Services
Proudly Part of Privia Health
Osteoarthritis is a degenerative disease that can affect any joint in the body. Being the most common form of arthritis, osteoarthritis affects millions of people around the world. Physiologically, osteoarthritis is resulted from stress on the joint, repetitive movements, and wear and tear. The damaged cartilage in the joint will cause inflammation and pain. At the same time, it restricts the range of motion in the joints. Being a progressive condition, the symptoms of osteoarthritis tend to worsen over time. There are many treatment options for osteoarthritis, including prescription medications, steroid injections, custom-molded orthotics, physical therapy, and lifestyle modification (e.g. weight reduction, low impact exercise). Apart from that, viscosupplementation injectables such as Supartz are used for the symptomatic treatment of osteoarthritis.
As we get older, our joint fluid levels decrease, which can lead to joint pain. Fluid loss can also be caused by Osteoarthritis, which will not get better without treatment. While conservative treatments are the mainstay of treatment for osteoarthritis, they may not work on all patients. For patients who have not had success with these treatments, doctors may utilize viscosupplementation, as second-line treatment. Viscosupplementation is a treatment that has a cushioning effect on the joint.
Supartz is a viscosupplementation injectable commonly used in the management of osteoarthritis pain. Supartz is an injectable, which contains fluid with a gel consistency. Supartz is a synthetic fluid designed to match the fluids that surround joints in the body. The fluid within joints helps to absorb shock and keep the joints lubricated. Having shock-absorbing properties, the gel-like fluid allows smooth movements between the bones.
Supartz is formulated with hyaluronic acid (hylan G-F 20 and sodium hyaluronate), a compound that mimics the actions of a natural substance in the joint. It lubricates the joint, helping the bones to move smoothly. As a result, pain can be significantly reduced, and patient joint mobility is improved.
The injections are performed at our office by Dr. John. Using a needle, the Supartz injection is injected into the affected joint space. It typically takes a few minutes to complete the procedure. The duration of action can be lasting for approximately 6 months but can vary from patient to patient.
As with all viscosupplementation injectables, Supartz is designed for symptomatic treatment, meaning this is not meant for patients who do not have joint-related pain of the Foot or Ankle. They do not cure the underlying causes of osteoarthritis, nor do they regenerate the injured or degraded cartilage.
Supartz is sourced from rooster combs; therefore, they should NOT be used in those with a known allergy to avian (bird) proteins, poultry, feathers, and/or egg products.
Anyone who has previously had any previous allergic reactions to Supartz therapy or similar material (hyaluronate products) should NOT have a Supartz Foot or Ankle joint injection.
Anyone with infections or skin diseases around the Foot or Ankle area should NOT have a Supartz Foot or Ankle injection.
If you are pregnant or lactating, we DON'T recommend that you have a Supartz Foot or Ankle injection, because its safety in pregnant/lactating women has never been studied.
You should also inform us if you have any blood clots or circulation problems in the legs.
Supartz has not been approved for use on anyone under the age of 21.
Supartz injection treatment is FDA approved for 5 weekly knee injections, but some patients report benefit from only 3 injections. (Some patients may experience benefits with as few as 3 injections given at weekly intervals. This has been noted in a study in which patients treated with 3 injections were evaluated for 90 days.) The number of required injections can vary in Foot and Ankle conditions when compared to the knee.
Dr. John believes the best protocol for Foot or Ankle injections is to perform a series of 3 weekly injections and then wait 4-6 weeks before determining whether or not you should have two additional injections. This protocol seems to provide the highest value for patients.
After receiving an injection, let the area rest for the next 48 hours. Try not to stand for longer than one hour at a time, and be sure to avoid strenuous activities such as running, jogging, or lifting weights.
After injection, patients may experience temporary pain and swelling at the site of injection. However, these symptoms tend to be short-lived and self-limiting in nature.
The largest clinical trial injections involved a series of 5 knee injections. The pain was the most common side-effect. 18.4% of Supartz injection patients reported pain as did 16% of control patients. Another common side-effect was arthralgia (defined as joint pain with no evidence of inflammation). This occurred in 12.6% of Supartz recipients and 15% of controls.
Other reported side effects include:
The progression of Ankle, Foot, and Toe osteoarthritis can lead to the inability to walk, stand, or even develop difficulty wearing shoes. This can significantly disrupt the daily functioning of patients. Current treatment modalities often can be used to manage the condition. Unfortunately, they do not always work. Being the second-line treatment of osteoarthritis, viscosupplements such as Supartz effectively reduce pain, providing lasting symptomatic relief. While there is currently no cure for osteoarthritis, it is possible to relieve its associated symptoms and slow the progression of the disease.